Horizon Kinetics Medical ETF (MEDX) seeks to provide exposure to healthcare companies through an actively managed approach focusing on medical innovation and healthcare services. This healthcare sector ETF targets companies involved in pharmaceuticals, biotechnology, medical devices, and healthcare technology across global markets.
How It Works
MEDX employs an active management strategy where portfolio managers select healthcare stocks based on fundamental research and growth potential rather than tracking a benchmark index. The fund focuses on companies with innovative medical technologies, strong competitive positions, and sustainable business models. Holdings are concentrated in higher-conviction positions with quarterly rebalancing based on ongoing research and market conditions. The strategy emphasizes quality healthcare companies across the entire medical value chain.
Key Features
- Active management by Horizon Kinetics allows for concentrated positions in highest-conviction healthcare opportunities versus passive diversification
- Zero expense ratio structure makes it one of the most cost-effective actively managed healthcare ETFs available
- Recently launched in January 2023, providing access to current healthcare innovation trends and emerging medical technologies
Risks
- This ETF can lose value if healthcare regulations change unfavorably or drug approvals fail, potentially causing 20-30% declines in individual holdings
- Active management concentration risk means poor stock selection could significantly underperform passive healthcare ETFs during market rallies
- Healthcare sector volatility can cause 15-25% swings during clinical trial results, FDA decisions, or broader market healthcare sentiment shifts
Who Should Own This
Best suited as a satellite holding (5-15% of portfolio) for investors with 3+ year time horizons seeking active healthcare exposure. Medium-to-high risk tolerance required due to sector concentration and active management volatility. Appropriate for investors wanting professional healthcare stock selection without researching complex biotech and pharmaceutical companies themselves.